Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer

AbstractInterleukin-31 is a crucial cytokine triggering inflammation which could be one of the risk factors of tumors. However, data for correlation betweenIL-31 and tumors are limited. The purpose of our study was to discuss whether genetic polymorphisms ofIL-31 were associated with the susceptibility and clinical outcomes of bladder cancer. Our study enrolled 478 controls, 156 non-muscle-invasive bladder cancer (NMIBC) and 138 muscle-invasive bladder cancer (MIBC) patients. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used for genotyping two single nucleotide polymorphisms (SNPs) ofIL-31 gene including rs7977932 and rs4758680. Our results showed that A allele and CA/AA genotypes of rs4758680 were associated with susceptibility to bladder cancer (P = 0.04, OR 1.32, 95% CI 1.01–1.72, andP = 0.02, OR 1.43, 95% CI 1.05–1.96, respectively), and G allele of rs7977932 might be a protect factor for tobacco smoking patients compared with non-smoking patients (P = 0.005, OR 0.42, 95% CI 0.23–0.76). Furthermore, CA/AA genotypes of rs4758680 might be the independent risk factors for the decreased recurrence-free survival of the patients with MIBC (P = 0.03, OR 2.02, 95% CI 1.06–3.85. Our data indicated that polymorphisms ofIL-31 are associated with bladder cancer, and rs4758680 could be an independent prediction for MIBC patients with a high risk of recurrence.
Source: Familial Cancer - Category: Cancer & Oncology Source Type: research